Perpetual Investment Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$2.4M Hold
46,923
0.29% 60
2022
Q3
$2.05M Hold
46,923
0.3% 62
2022
Q2
$2.46M Hold
46,923
0.36% 61
2022
Q1
$2.43M Hold
46,923
0.31% 85
2021
Q4
$2.77M Sell
46,923
-13,700
-23% -$679K 0.32% 91
2021
Q3
$2.61M Hold
60,623
0.33% 93
2021
Q2
$2.37M Buy
60,623
+5,500
+10% +$214K 0.34% 93
2021
Q1
$1.99M Hold
55,123
0.33% 68
2020
Q4
$2.02M Buy
+55,123
New +$2.02M 0.3% 85

Other funds holding PFE

Perpetual Investment Management's PFE Position: Q4 2022 in Review

Perpetual Investment Management held its Pfizer (PFE) position steady in Q4 2022 at 46,923 shares worth $2.4M. The position accounts for 0.29% of the portfolio, ranked #60.

Perpetual Investment Management first reported a position in PFE in Q4 2020 and has held it in 9 quarters since. The position peaked at $2.77M in Q4 2021. 3,268 funds tracked by Wall St. Rank hold PFE as of Q4 2022.

  • Perpetual Investment Management held 46,923 shares of Pfizer worth $2.4M as of Q4 2022.
  • Perpetual Investment Management left its Pfizer share count unchanged in Q4 2022.
  • Pfizer made up 0.29% of Perpetual Investment Management's portfolio in Q4 2022, its #60 holding.
  • Perpetual Investment Management first reported a position in Pfizer in Q4 2020 and has held it in 9 quarters since.
  • Perpetual Investment Management's Pfizer position peaked at $2.77M in Q4 2021.
  • 3,268 funds tracked by Wall St. Rank held Pfizer as of Q4 2022.

Based on Perpetual Investment Management's 13F filing for Q4 2022, filed 14 Feb 2023.